Lipid-lowering drugs and risk of psoriasis: a mendelian randomisation study

Medicine and Dentistry

• Psoriasis 100%
• Low-Density Lipoprotein 40%
• Hypolipidemic Agent 30%
• Association 20%
• Pathogenesis 20%
• Lipid 20%
• Mendelian Randomization Analysis 20%
• Pleiotropy 20%
• Statin 20%
• Drug 10%
• Chemotherapeutic Agent 10%
• Diseases 10%
• Genome Wide Association Study 10%
• Biological Marker 10%
• Measurement 10%
• Genetic Association 10%
• Ezetimibe 10%
• Hydroxymethylglutaryl Coenzyme A Reductase 10%
• Proprotein Convertase 9 10%
• Alirocumab 10%

Biochemistry, Genetics and Molecular Biology

• Lipid 50%
• Low-Density Lipoprotein 40%
• Genetics 30%
• PCSK9 30%
• Sensitivity Analysis 20%
• Association 20%
• Statin 20%
• Statin 20%
• Mendelian Randomization 20%
• Pleiotropy 20%
• Sample 10%
• Reduction (Chemistry) 10%
• Genome-Wide Association Study 10%
• Genetic Association 10%
• HMG-CoA Reductase 10%
• Subtilisin 10%
• Proprotein Convertase 10%
• Kexin 10%